Silence Therapeutics

Company

An siRNA company that has an Lp(a) inhibitor in development, but has not yet released its phase one study.

Mentioned in 1 video

Videos Mentioning Silence Therapeutics

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

An siRNA company that has an Lp(a) inhibitor in development, but has not yet released its phase one study.